PubMed:32213337 / 1149-1296 JSONTXT

{"project":"LitCovid-OGER-BB","denotations":[{"id":"T35","span":{"begin":0,"end":8},"obj":"GO:0042571"},{"id":"T36","span":{"begin":28,"end":38},"obj":"SP_7"},{"id":"T37","span":{"begin":48,"end":61},"obj":"PG_4"},{"id":"T38","span":{"begin":71,"end":78},"obj":"GO:0009986"},{"id":"T39","span":{"begin":110,"end":116},"obj":"SO:0000417"}],"namespaces":[{"prefix":"NCBITaxon","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"}],"text":"Antibody levels against the SARS-CoV-2 internal nucleoprotein (NP) and surface spike protein receptor binding domain (RBD) were measured using EIA."}

{"project":"LitCovid-OGER","denotations":[{"id":"T17","span":{"begin":0,"end":8},"obj":"GO:0042571"},{"id":"T4","span":{"begin":28,"end":32},"obj":"PR:000014459"}],"namespaces":[{"prefix":"PR","uri":"http://purl.obolibrary.org/obo/PR_"},{"prefix":"UBERON","uri":"http://purl.obolibrary.org/obo/UBERON_"}],"text":"Antibody levels against the SARS-CoV-2 internal nucleoprotein (NP) and surface spike protein receptor binding domain (RBD) were measured using EIA."}

{"project":"LitCovid-sentences-v1","denotations":[{"id":"TextSentencer_T12","span":{"begin":0,"end":147},"obj":"Sentence"}],"text":"Antibody levels against the SARS-CoV-2 internal nucleoprotein (NP) and surface spike protein receptor binding domain (RBD) were measured using EIA."}

{"project":"LitCovid-TimeML","denotations":[{"id":"tok187","span":{"begin":0,"end":8},"obj":"NNP"},{"id":"tok188","span":{"begin":9,"end":15},"obj":"NNS"},{"id":"tok189","span":{"begin":16,"end":23},"obj":"IN"},{"id":"tok190","span":{"begin":24,"end":27},"obj":"DT"},{"id":"tok191","span":{"begin":28,"end":37},"obj":"NNP"},{"id":"tok192","span":{"begin":37,"end":38},"obj":"CD"},{"id":"tok193","span":{"begin":39,"end":47},"obj":"JJ"},{"id":"tok194","span":{"begin":48,"end":61},"obj":"NN"},{"id":"tok195","span":{"begin":62,"end":63},"obj":"("},{"id":"tok196","span":{"begin":63,"end":65},"obj":"NNP"},{"id":"tok197","span":{"begin":65,"end":66},"obj":")"},{"id":"tok198","span":{"begin":67,"end":70},"obj":"CC"},{"id":"tok199","span":{"begin":71,"end":78},"obj":"NN"},{"id":"tok200","span":{"begin":79,"end":84},"obj":"NN"},{"id":"tok201","span":{"begin":85,"end":92},"obj":"NN"},{"id":"tok202","span":{"begin":93,"end":101},"obj":"NN"},{"id":"tok203","span":{"begin":102,"end":109},"obj":"JJ"},{"id":"tok204","span":{"begin":110,"end":116},"obj":"NN"},{"id":"tok205","span":{"begin":117,"end":118},"obj":"("},{"id":"tok206","span":{"begin":118,"end":121},"obj":"NNP"},{"id":"tok207","span":{"begin":121,"end":122},"obj":")"},{"id":"tok208","span":{"begin":123,"end":127},"obj":"VBD"},{"id":"tok209","span":{"begin":128,"end":136},"obj":"VBN"},{"id":"tok210","span":{"begin":137,"end":142},"obj":"VBG"},{"id":"tok211","span":{"begin":143,"end":146},"obj":"NNP"},{"id":"tok212","span":{"begin":146,"end":147},"obj":"."},{"id":"event16","span":{"begin":137,"end":142},"obj":"OCCURRENCE"}],"text":"Antibody levels against the SARS-CoV-2 internal nucleoprotein (NP) and surface spike protein receptor binding domain (RBD) were measured using EIA."}

{"project":"LitCovid-PD-MONDO-v1","denotations":[{"id":"T12","span":{"begin":28,"end":36},"obj":"Disease"}],"attributes":[{"id":"A12","pred":"mondo_id","subj":"T12","obj":"http://purl.obolibrary.org/obo/MONDO_0005091"}],"text":"Antibody levels against the SARS-CoV-2 internal nucleoprotein (NP) and surface spike protein receptor binding domain (RBD) were measured using EIA."}

{"project":"LitCovid-PD-FMA-UBERON-v1","denotations":[{"id":"T14","span":{"begin":0,"end":8},"obj":"Body_part"},{"id":"T15","span":{"begin":85,"end":92},"obj":"Body_part"}],"attributes":[{"id":"A14","pred":"fma_id","subj":"T14","obj":"http://purl.org/sig/ont/fma/fma62871"},{"id":"A15","pred":"fma_id","subj":"T15","obj":"http://purl.org/sig/ont/fma/fma67257"}],"text":"Antibody levels against the SARS-CoV-2 internal nucleoprotein (NP) and surface spike protein receptor binding domain (RBD) were measured using EIA."}